Apelanio, Mark John S.
HRN: 16-91-90 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2023
CO-AMOXICLAV 625MG (TAB)
01/08/2023
01/14/2023
PO
625
BID
Abrasions
Waiting Final Action
01/08/2023
MUPIROCIN 2%, 15G (TUBE)
01/08/2023
01/14/2023
TOPICAL
5%
BID
Abrasion
Waiting Final Action